Literature DB >> 18166768

Reduced intensity conditioning haematopoietic stem cell transplantation with mesenchymal stromal cells infusion for the treatment of metachromatic leukodystrophy: a case report.

N Meuleman1, G Vanhaelen, T Tondreau, P Lewalle, J Kwan, J Bennani, P Martiat, L Lagneaux, D Bron.   

Abstract

We report the case of a 23-year-old woman who presented with an adult form of metachromatic leukodystrophy (MLD) evolving over one year with a progressive neurological deterioration. A non-myeloablative matched related haematopoietic stem cell transplantation (HSCT) with concomitant mesenchymal stromal cells (MSCs) infusion was performed. Engraftment occurred rapidly with no significant toxicity or side effects following the MSC infusion. At a follow up of 40 months, the patient had a stabilisation of all neurological manifestations of her disease. This case report suggests the feasibility and the potential efficacy of reduced intensity conditioning (RIC) allogeneic HSCT combined with MSC infusion for patients with the adult form of MLD.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18166768     DOI: 10.3324/haematol.11802

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  8 in total

1.  Delivering drugs to the central nervous system: an overview.

Authors:  Patricia I Dickson
Journal:  Drug Deliv Transl Res       Date:  2012-06       Impact factor: 4.617

2.  Hematopoietic SCT: a useful treatment for late metachromatic leukodystrophy.

Authors:  M Solders; D A Martin; C Andersson; M Remberger; T Andersson; O Ringdén; G Solders
Journal:  Bone Marrow Transplant       Date:  2014-05-05       Impact factor: 5.483

3.  Global transcriptome analysis of human bone marrow stromal cells (BMSC) reveals proliferative, mobile and interactive cells that produce abundant extracellular matrix proteins, some of which may affect BMSC potency.

Authors:  Jiaqiang Ren; Ping Jin; Marianna Sabatino; Arun Balakumaran; Ji Feng; Sergei A Kuznetsov; Harvey G Klein; Pamela G Robey; David F Stroncek
Journal:  Cytotherapy       Date:  2011-01-20       Impact factor: 5.414

4.  Long-term functional engraftment of mesenchymal progenitor cells in a mouse model of accelerated aging.

Authors:  Lakshman Singh; Tracy A Brennan; Jung-Hoon Kim; Kevin P Egan; Emily A McMillan; Qijun Chen; Kurt D Hankenson; Yi Zhang; Stephen G Emerson; F Brad Johnson; Robert J Pignolo
Journal:  Stem Cells       Date:  2013-03       Impact factor: 6.277

5.  The establishment of a bank of stored clinical bone marrow stromal cell products.

Authors:  Marianna Sabatino; Jiaqiang Ren; Virginia David-Ocampo; Lee England; Michael McGann; Minh Tran; Sergei A Kuznetsov; Hanh Khuu; Arun Balakumaran; Harvey G Klein; Pamela G Robey; David F Stroncek
Journal:  J Transl Med       Date:  2012-02-06       Impact factor: 5.531

Review 6.  Cell adhesion and long-term survival of transplanted mesenchymal stem cells: a prerequisite for cell therapy.

Authors:  Seahyoung Lee; Eunhyun Choi; Min-Ji Cha; Ki-Chul Hwang
Journal:  Oxid Med Cell Longev       Date:  2015-02-02       Impact factor: 6.543

Review 7.  Mesenchymal Stem Cell-Based Therapy for Lysosomal Storage Diseases and Other Neurodegenerative Disorders.

Authors:  Shaza S Issa; Alisa A Shaimardanova; Victor V Valiullin; Albert A Rizvanov; Valeriya V Solovyeva
Journal:  Front Pharmacol       Date:  2022-03-02       Impact factor: 5.810

Review 8.  Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches.

Authors:  Alisa A Shaimardanova; Daria S Chulpanova; Valeriya V Solovyeva; Aysilu I Mullagulova; Kristina V Kitaeva; Cinzia Allegrucci; Albert A Rizvanov
Journal:  Front Med (Lausanne)       Date:  2020-10-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.